期刊
MODERN RHEUMATOLOGY
卷 25, 期 1, 页码 79-84出版社
TAYLOR & FRANCIS LTD
DOI: 10.3109/14397595.2014.914016
关键词
Apoptosis; IL-6; Monocytes; Rheumatoid arthritis; Tocilizumab
类别
资金
- Parents'Association Grant from Kitasato University School of Medicine
- Mitsubishi Tanabe Pharma Co., Tokyo
- Takeda Pharmaceutical Co., Tokyo
- Chugai Pharmaceutical Co., Tokyo, Japan
- Grants-in-Aid for Scientific Research [15K09556] Funding Source: KAKEN
Objective. To explore the effects of anti-IL-6 receptor antibody, tocilizumab on function of human monocytes. Methods. Monocytes from healthy donors were cultured in the presence of staphylococcal enterotoxin B (SEB) with pharmacologically attainable concentrations of tocilizumab or control IgG. The expression of IL-6 mRNA was determined using quantitative RT-PCR. The expression of CD80 and CD86 and the induction of apoptosis of monocytes were measured using flow cytometry. Results. Tocilizumab promoted apoptosis of SEB-stimulated monocytes. The induction of apoptosis of monocytes by tocilizumab were reversed by addition of IgG, but not IgG F(ab')(2) fragments. Tocilizumab significantly suppressed the expression of CD80, but not that of CD86, on SEB-stimulated monocytes. Finally, tocilizumab significantly suppressed the expression of mRNA for IL-6 of monocytes stimulated with SEB. Conclusions. These results demonstrate that one of the mechanism of action of tocilizumab involves the induction of apoptosis of monocytes, which requires interaction with Fc receptor on monocytes. Moreover, the data also indicate that tocilizumab inhibit IL-6 production of monocytes at mRNA levels.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据